{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:58:39Z","timestamp":1788260319859,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007033","name":"Eisai Korea Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jpba.2024.116652","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T20:24:16Z","timestamp":1735071856000},"page":"116652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["An exploratory multi-omics study reveals distinct molecular signatures of ulcerative colitis and Crohn's disease and their correlation with disease activity"],"prefix":"10.1016","volume":"255","author":[{"given":"Nguyen Tran Nam","family":"Tien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Quang","family":"Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc Ninh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-0546","authenticated-orcid":false,"given":"Nguyen Phuoc","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Sub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2024.116652_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"27","key":"10.1016\/j.jpba.2024.116652_bib2","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of Inflammatory Bowel Diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jpba.2024.116652_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1053\/j.gastro.2021.12.246","article-title":"Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?","volume":"162","author":"Verstockt","year":"2022","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jpba.2024.116652_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","article-title":"Current best practice for disease activity assessment in IBD","volume":"13","author":"Walsh","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.jpba.2024.116652_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrgastro.2015.135","article-title":"Biologic agents for IBD: practical insights","volume":"12","author":"Danese","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jpba.2024.116652_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/humu.22080","article-title":"Deep phenotyping for precision medicine","volume":"33","author":"Robinson","year":"2012","journal-title":"Hum. Mutat."},{"issue":"7576","key":"10.1016\/j.jpba.2024.116652_bib7","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/527S14a","article-title":"Deep phenotyping: The details of disease","volume":"527","author":"Delude","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpba.2024.116652_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ecco-jcc\/jjy158","article-title":"Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review","volume":"13","author":"Gisbert","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"5","key":"10.1016\/j.jpba.2024.116652_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ecco-jcc\/jjaa227","article-title":"Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review","volume":"15","author":"Gallagher","year":"2021","journal-title":"J. Crohns Colitis"},{"issue":"11","key":"10.1016\/j.jpba.2024.116652_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/ph14111190","article-title":"Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review","volume":"14","author":"Aldars-Garc\u00eda","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.jpba.2024.116652_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4062\/biomolther.2021.125","article-title":"Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease","volume":"29","author":"Lee","year":"2021","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"6","key":"10.1016\/j.jpba.2024.116652_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","volume":"19","author":"Agrawal","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jpba.2024.116652_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/ecco-jcc\/jjac027","article-title":"Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All","volume":"16","author":"Sudhakar","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.jpba.2024.116652_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease","volume":"54","author":"Costa","year":"2005","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jpba.2024.116652_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ibd.20933","article-title":"Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.jpba.2024.116652_bib16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/ijms24031987","article-title":"Optimization of Mobile Phase Modifiers for Fast LC-MS-Based Untargeted Metabolomics and Lipidomics","volume":"24","author":"Cajka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116652_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116126","article-title":"Omics analysis unveils changes in the metabolome and lipidome of Caenorhabditis elegans upon polydopamine exposure","volume":"244","author":"Nguyen","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.jpba.2024.116652_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167064","article-title":"Metabolic phenotyping and global functional analysis facilitate metabolic signature discovery for tuberculosis treatment monitoring","volume":"1870","author":"Anh","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"issue":"6","key":"10.1016\/j.jpba.2024.116652_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Methods"},{"issue":"W1","key":"10.1016\/j.jpba.2024.116652_bib20","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"10.1016\/j.jpba.2024.116652_bib21","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.jpba.2024.116652_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R package for 'omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput. Biol."},{"issue":"17","key":"10.1016\/j.jpba.2024.116652_bib23","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","article-title":"DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays","volume":"35","author":"Singh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpba.2024.116652_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.jpba.2024.116652_bib25","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","article-title":"The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease","volume":"18","author":"Di Ciaula","year":"2023","journal-title":"Intern. Emerg. Med."},{"issue":"1","key":"10.1016\/j.jpba.2024.116652_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability \u2013 a new target for disease prevention and therapy","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116652_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","article-title":"Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116652_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mi.2016.14","article-title":"Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications","volume":"9","author":"Boyapati","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jpba.2024.116652_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100150","article-title":"Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism","volume":"62","author":"Kersten","year":"2021","journal-title":"J. Lipid Res."},{"issue":"21","key":"10.1016\/j.jpba.2024.116652_bib30","doi-asserted-by":"crossref","first-page":"11682","DOI":"10.3390\/ijms222111682","article-title":"Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases","volume":"22","author":"Boldyreva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jpba.2024.116652_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202249866","article-title":"Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases","volume":"53","author":"Kayama","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jpba.2024.116652_bib32","article-title":"Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn\u2019s Disease and Ulcerative Colitis Compared With Healthy Control Individuals","author":"Tews","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.jpba.2024.116652_bib33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/aps.2015.73","article-title":"Novel endogenous angiogenesis inhibitors and their therapeutic potential","volume":"36","author":"Rao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.jpba.2024.116652_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00011-023-01753-9","article-title":"Dual role of ANGPTL4 in inflammation","volume":"72","author":"Zuo","year":"2023","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.jpba.2024.116652_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2022.03.153","article-title":"Increased angiopoietin-like 4 expression ameliorates inflammatory bowel diseases via suppressing CD8+\u2009T cell activities","volume":"612","author":"Zhang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:16:28Z","timestamp":1769688988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S0731708524006940"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116652","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An exploratory multi-omics study reveals distinct molecular signatures of ulcerative colitis and Crohn's disease and their correlation with disease activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116652"}}